WallStreetZenWallStreetZen

NASDAQ: XCUR
Exicure Inc Stock

$2.25-0.33 (-12.79%)
Updated Oct 15, 2024
XCUR Price
$2.25
Fair Value Price
-$0.73
Market Cap
$3.89M
52 Week Low
$1.44
52 Week High
$6.00
P/E
-0.49x
P/B
2.41x
P/S
5.54x
PEG
N/A
Dividend Yield
N/A
Revenue
$500.00k
Earnings
-$8.17M
Gross Margin
100%
Operating Margin
-1,633.2%
Profit Margin
-1,634.4%
Debt to Equity
5.63
Operating Cash Flow
-$4M
Beta
0.95
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

XCUR Overview

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how XCUR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

XCUR ($2.25) is overvalued by 408.28% relative to our estimate of its Fair Value price of -$0.73 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
XCUR ($2.25) is not significantly undervalued (408.28%) relative to our estimate of its Fair Value price of -$0.73 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
XCUR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more XCUR due diligence checks available for Premium users.

Be the first to know about important XCUR news, forecast changes, insider trades & much more!

XCUR News

Valuation

XCUR fair value

Fair Value of XCUR stock based on Discounted Cash Flow (DCF)
Price
$2.25
Fair Value
-$0.73
Undervalued by
408.28%
XCUR ($2.25) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
XCUR ($2.25) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
XCUR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

XCUR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.49x
Industry
-141.41x
Market
26.94x

XCUR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.41x
Industry
6.09x
XCUR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

XCUR's financial health

Profit margin

Revenue
$0.0
Net Income
-$600.0k
Profit Margin
0%
XCUR's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
XCUR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$10.7M
Liabilities
$9.1M
Debt to equity
5.63
XCUR's short-term liabilities ($3.43M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XCUR's long-term liabilities ($5.64M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XCUR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
XCUR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.2M
Investing
$0.0
Financing
$1.0M
XCUR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

XCUR vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
XCUR$3.89M-12.79%-0.49x2.41x
SNPX$3.94M+6.38%0.58x0.21x
AZTR$3.97M+2.36%0.01x2.30x
CNSP$3.99M0.00%-0.00x-0.93x
ENVB$3.77M+2.67%-0.12x0.70x

Exicure Stock FAQ

What is Exicure's quote symbol?

(NASDAQ: XCUR) Exicure trades on the NASDAQ under the ticker symbol XCUR. Exicure stock quotes can also be displayed as NASDAQ: XCUR.

If you're new to stock investing, here's how to buy Exicure stock.

What is the 52 week high and low for Exicure (NASDAQ: XCUR)?

(NASDAQ: XCUR) Exicure's 52-week high was $6.00, and its 52-week low was $1.44. It is currently -62.5% from its 52-week high and 56.25% from its 52-week low.

How much is Exicure stock worth today?

(NASDAQ: XCUR) Exicure currently has 1,730,241 outstanding shares. With Exicure stock trading at $2.25 per share, the total value of Exicure stock (market capitalization) is $3.89M.

Exicure stock was originally listed at a price of $465.01 in May 22, 2018. If you had invested in Exicure stock at $465.01, your return over the last 6 years would have been -99.52%, for an annualized return of -58.87% (not including any dividends or dividend reinvestments).

How much is Exicure's stock price per share?

(NASDAQ: XCUR) Exicure stock price per share is $2.25 today (as of Oct 15, 2024).

What is Exicure's Market Cap?

(NASDAQ: XCUR) Exicure's market cap is $3.89M, as of Oct 16, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Exicure's market cap is calculated by multiplying XCUR's current stock price of $2.25 by XCUR's total outstanding shares of 1,730,241.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.